Stellaromics provides tools for 3D tissue analysis by reading multiple molecular layers at once. Its Pyxa platform enables three-dimensional spatial multi-omics to map gene expression across tissues. A core component, STARmap, measures thousands of genes in a tissue sample to reveal cellular function and organization in 3D. The company sells the Pyxa platform and services to research institutions and pharma collaborators to advance neuroscience and cancer research.
Company Size
51-200
Company Stage
Series B
Total Funding
$105M
Headquarters
Natick, Massachusetts
Founded
2022
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?